Abubakar, M. B. (2017). The impact of CYP3A4 and CYP3A5 polymorphisms on anastrozole's pharmacokinetics and pharmacodynamics in post-menopausal breast cancer patients.
Chicago Style (17th ed.) CitationAbubakar, Murtala Bello. The Impact of CYP3A4 and CYP3A5 Polymorphisms on Anastrozole's Pharmacokinetics and Pharmacodynamics in Post-menopausal Breast Cancer Patients. 2017.
MLA (9th ed.) CitationAbubakar, Murtala Bello. The Impact of CYP3A4 and CYP3A5 Polymorphisms on Anastrozole's Pharmacokinetics and Pharmacodynamics in Post-menopausal Breast Cancer Patients. 2017.
Warning: These citations may not always be 100% accurate.